ERBB2 and breast cancer: In the multivariable analysis, the HR for OS of HER2-low BC compared with HER2 0 BC was 0.94 (95% CI: 0.90; 0.99, p = 0.002) with a statistically significant test of heterogeneity at p = 0.02.